Images List Premium Download Classic

Inflammatory Disease

Inflammatory Disease-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Methods for treating vascular leak syndrome and cancer
Aerpio Therapeutics, Inc.
January 11, 2018 - N°20180009890

Disclosed are methods for treating vascular leak syndrome and preventing cancer metastasis. Further disclosed are methods for treating vascular leakage due to inflammatory diseases, sepsis, cancer or the presence of pathogens.
Peptide for treating inflammatory diseases
Aerpio Therapeutics, Inc.
January 11, 2018 - N°20180009860

The present invention provides a peptide having anti-inflammatory activity. The present invention also provides the method of preparation of the peptide and compositions, and kits comprising the peptide. The invention further provides the method of treating inflammatory diseases employing the peptide of the present invention.
Heterocyclic compounds and use thereof
National Health Research Institutes
January 11, 2018 - N°20180009786

Heterocyclic compounds of formula (i) shown herein. Also disclosed are pharmaceutical compositions containing the heterocyclic compounds and methods of using the heterocyclic compounds to mobilize hematopoietic stem cells and endothelial progenitor cells into the peripheral circulation. Further provided are methods for treating tissue injury, cancer, inflammatory disease, and autoimmune disease with the heterocyclic compounds.
Inflammatory Disease Patent Pack
Download 291+ patent application PDFs
Inflammatory Disease Patent Applications
Download 291+ Inflammatory Disease-related PDFs
For professional research & prior art discovery
inventor
  • 291+ full patent PDF documents of Inflammatory Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or ...
Abbott Laboratories
January 11, 2018 - N°20180008623

Disclosed are nutritional compositions including human milk oligosaccharides and nucleotides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
Methods of treating neurological inflammatory disorders
Mayo Foundation For Medical Education And Research
January 11, 2018 - N°20180008620

Methods of treating neurological inflammatory disease or seizures caused by neuroinflammation by administering cpmp are described. Treating neuroinflammatory and neurometabolic diseases with cpmp is described so as to override dyshomeostasis in the moco synthesis pathway and control synaptic inhibition in the gephyrin-gabar pathway. This is a novel strategy for preventing neural circuit dyshomeostasis by stabilizing inhibitory synapses.
2-oxo-1,2-dihydrobenzo[cd]indole compound and use thereof
Guangzhou Institutes Of Biomediciene And Health, Chinese Academy Of Sciences
January 11, 2018 - N°20180008574

The present invention relates to the technical field of medicinal chemistry, and in particular discloses a 2-oxo-1,2-dihydrobenzo[cd]indole compound and use thereof. The compound and pharmaceutically acceptable salt, isomer, racemate, prodrug, co-crystallized complex, hydrate, and solvate thereof can effectively inhibit the bet bromodomain receptor, and can be used for preparing a medicine for treating cancers, cell proliferative disorders, ...
Inflammatory Disease Patent Pack
Download 291+ patent application PDFs
Inflammatory Disease Patent Applications
Download 291+ Inflammatory Disease-related PDFs
For professional research & prior art discovery
inventor
  • 291+ full patent PDF documents of Inflammatory Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Bicyclic compound
University Of South Florida
January 04, 2018 - N°20180002322

Wherein each symbol is as described in the description, or a salt thereof has an acetyl-coa carboxylase inhibitory action, is useful for the prophylaxis or treatment of cancer, inflammatory diseases and the like, and has superior efficacy.
Novel compound useful for the treatment of degenerative and inflammatory diseases
Galapagos Nv
January 04, 2018 - N°20180000831

A novel compound able to inhibit jak is disclosed, this compound may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/...
Treatment of th17 mediated inflammatory diseases
Genentech, Inc.
December 28, 2017 - N°20170369885

The present invention provides methods and means to reduce inflammation associated with irf-4, ap-1 and th17 mediated diseases. In particular, the invention provides methods and means to treat multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, and psoriasis and related conditions.
Oxidized lipids and methods of use thereof
Vascular Biogenics Ltd.
December 28, 2017 - N°20170369516

The present invention is directed to oxidized lipids and pharmaceutical compositions comprising the same. The present invention is also directed to methods of making an oxidized lipid of the invention and to methods of treating or preventing fibrosis or inflammatory diseases or disorders comprising an oxidized lipid of the invention.
Cyclic compounds and uses thereof
Karyopharm Therapeutics Inc.
December 28, 2017 - N°20170369470

The invention generally relates to substituted benzothiophenyl, substituted benzothiazolyl, substituted indolyl and substituted benzoimidazolyl compounds and, more particularly, to a compound represented by structural formula i: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula i, or a pharmaceutically acceptable ...
Cyclodextrin-based polymers for therapeutic delivery
Cerulean Pharma Inc.
December 28, 2017 - N°20170368194

Provided are methods relating to the use of cdp-therapeutic agent conjugates for the treatment of a disease or disorder, e. G., autoimmune disease, inflammatory disease, central nervous system disorder, cardiovascular disease, or metabolic disorder. Also provided are cdp-therapeutic agent conjugates, particles comprising cdp-therapeutic agent conjugates, and compositions comprising cdp-therapeutic agent conjugates.
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
Celgene Corporation
December 21, 2017 - N°20170362240

Compounds of formula i: and stereoisomers and pharmaceutically acceptable salts and solvates thereof in which r1, r2, r3 and r4 have the meanings given in the specification, are inhibitors of one or more jak kinases and are useful in the treatment of jak kinase-associated diseases and disorders, such as autoimmune diseases, inflammatory diseases, rejection of transplanted organs, tissues and cells, ...
Inflammatory Disease Patent Pack
Download 291+ patent application PDFs
Inflammatory Disease Patent Applications
Download 291+ Inflammatory Disease-related PDFs
For professional research & prior art discovery
inventor
  • 291+ full patent PDF documents of Inflammatory Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Novel compounds
Celgene Corporation
December 21, 2017 - N°20170362208

Wherein r1, r2a, r2b, r3, r4, l, x, r5 and r6 are as defined in the description for use in the treatment of inflammatory diseases.
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
Tes Pharma S.r.l.
December 21, 2017 - N°20170362185

The present disclosure discloses compounds capable of modulating the activity of α-amino-β-carboxymuconic acid semialdehyde decarboxylase (acmsd), which are useful for the prevention and/or the treatment of diseases and disorders associated with defects in nad+ biosynthesis, e. G., metabolic disorders, neurodegenerative diseases, chronic inflammatory diseases, kidney diseases, and diseases associated with ageing. The present application ...
Drug delivery conjugates containing unnatural amino acids and methods for using
Endocyte, Inc.
December 21, 2017 - N°20170360950

Described herein are drug delivery conjugates for targeted therapy. In particular, described herein are drug delivery conjugates that include polyvalent linkers comprising one or more unnatural amino acids that are useful for treating cancers and inflammatory diseases.
Inflammatory disease
Clinuvel Ag
December 21, 2017 - N°20170360896

The present invention is directed to alpha-msh analogues for treatment of inflammatory disease.
Solid solution compositions and use in chronic inflammation
Infirst Healthcare Limited
December 21, 2017 - N°20170360702

The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
Inhibitors of lactate transporters for use in the treatment of inflammatory diseases
Queen Mary University Of London
December 14, 2017 - N°20170355987

The present invention provides methods and compositions for the treatment of inflammatory diseases such as rheumatoid arthritis using inhibitors of lactate transporters.
Heterocyclic derivatives as rorgamma modulators
Genfit
December 07, 2017 - N°20170349582

The present invention provides novel compounds of formula (i) that are modulators of rorgamma. These compounds, and pharmaceutical compositions comprising the same, are suitable means for treating any disease wherein the modulation of rorgamma has therapeutic effects, for instance in autoimmune diseases, autoimmune-related diseases, inflammatory diseases, fibrotic diseases, or cholestatic diseases.
Serine/threonine kinase inhibitors
Genentech, Inc.
December 07, 2017 - N°20170348310

Compounds of formula i or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of hyperproliferative, pain and inflammatory diseases. Methods of using compounds of formula i or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian ...
Loading